MD · Pediatrix Medical Group, Inc.
$26.26
+2.75% last session
End-of-day data · updated 2026-07-28
Market cap
—
Enterprise value
$2B
Trailing P/E
12.7
Forward P/E
11.1
Dividend yield
—
Beta
0.66
Avg volume
1M
Employees
4K
2D change
-0.46%
5D change
2.19%
10D change
0.04%
30D change
5.92%
60D change
21.36%
MTD change
0.00%
YTD change
22.21%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MD
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-14
Latest call per bank · past 12 months
UBS
Neutral$25.00
-4.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-14 | Truist Securities | Maintains | Hold | $23.00 → $28.00 |
| 2026-05-12 | UBS | Maintains | Neutral | $22.00 → $25.00 |
| 2026-04-13 | Truist Securities | Maintains | Hold | $21.00 → $23.00 |
| 2026-02-24 | UBS | Maintains | Neutral | $23.00 → $22.00 |
| 2026-02-20 | Truist Securities | Maintains | Hold | $24.00 → $21.00 |
| 2025-11-10 | Truist Securities | Maintains | Hold | $17.00 → $24.00 |
| 2025-11-05 | UBS | Maintains | Neutral | $16.50 → $23.00 |
| 2025-09-05 | Leerink Partners | Maintains | Market Perform | $14.50 → $17.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 60 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 11.0% above the 50-day MA ($24.19).
- Price vs 200-day MA: Trading 22.8% above the 200-day MA ($21.88).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.08) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($27.39).
MD Price Chart
Loading chart for MD…
Fundamentals
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.